tradingkey.logo
怜玢
マヌケット
ニュヌス
分析
ツヌル
株匏スクリヌナヌ


English
繁䜓䞭文
à¹„àž—àž¢
Tiếng việt
简䜓䞭文
Español
Português
Deutsch
한국얎
日本語

tradingkey.logo
怜玢



Savara Inc

SVRA
りォッチリストに远加
5.500USD
+0.120+2.23%
終倀 06/18, 16:00ET15分遅れの株䟡
1.13B時䟡総額
損倱額盎近12ヶ月PER

Savara Inc

5.500
+0.120+2.23%
抂芁
金融
ディスカッション
分析
䌁業名
プロフィヌル収益株䞻統蚈䌁業情報

抂芁

金融

ディスカッション

分析

䌁業名

プロフィヌル収益株䞻統蚈䌁業情報

株䞻

曎新時刻: Sun, May 10
曎新時刻: Sun, May 10
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
New Enterprise Associates (NEA)
11.94%
Bain Capital Life Sciences Investors, LLC
7.22%
VR Adviser, LLC
6.71%
Deerfield Management Company, L.P.
6.62%
TCG Crossover Management, LLC
6.03%
他の
61.48%
株䞻統蚈
株䞻統蚈
比率
New Enterprise Associates (NEA)
11.94%
Bain Capital Life Sciences Investors, LLC
7.22%
VR Adviser, LLC
6.71%
Deerfield Management Company, L.P.
6.62%
TCG Crossover Management, LLC
6.03%
他の
61.48%
皮類
株䞻統蚈
比率
Investment Advisor
33.21%
Investment Advisor/Hedge Fund
20.16%
Hedge Fund
19.11%
Venture Capital
18.81%
Private Equity
5.98%
Individual Investor
2.58%
Research Firm
1.89%
Bank and Trust
0.27%
Pension Fund
0.04%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
324
213.87M
104.36%
+19.14M
2025Q4
295
181.54M
89.22%
-12.10M
2025Q3
286
169.85M
86.94%
-21.45M
2025Q2
295
181.81M
105.19%
-8.48M
2025Q1
306
176.74M
102.29%
-9.64M
2024Q4
294
173.80M
101.27%
-5.45M
2024Q3
274
169.68M
103.28%
+3.87M
2024Q2
257
157.29M
95.89%
+28.15M
2024Q1
230
131.01M
94.21%
-92.17K
2023Q4
197
123.19M
91.03%
-2.15M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
New Enterprise Associates (NEA)
24.47M
11.96%
--
--
Dec 31, 2025
Bain Capital Life Sciences Investors, LLC
14.79M
7.23%
-2.81M
-15.97%
Dec 31, 2025
VR Adviser, LLC
13.74M
6.71%
+1.06M
+8.35%
Dec 31, 2025
Deerfield Management Company, L.P.
13.57M
6.63%
--
--
Dec 31, 2025
TCG Crossover Management, LLC
12.36M
6.04%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
10.09M
4.93%
+2.49M
+32.79%
Dec 31, 2025
Frazier Life Sciences Management, L.P.
9.86M
4.82%
-1.60M
-13.96%
Dec 31, 2025
Polar Capital LLP
8.31M
4.06%
+8.31M
--
Dec 31, 2025
Nantahala Capital Management, LLC
7.34M
3.59%
-1.43M
-16.30%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Virtus LifeSci Biotech Clinical Trials ETF
1.24%
Texas Capital Texas Small Cap Equity Index ETF
0.24%
ProShares Ultra Nasdaq Biotechnology
0.13%
iShares Micro-Cap ETF
0.09%
Invesco Nasdaq Biotechnology ETF
0.07%
Texas Capital Texas Equity Index ETF
0.05%
iShares Biotechnology ETF
0.03%
ProShares Hedge Replication ETF
0.03%
Invesco RAFI US 1500 Small-Mid ETF
0.03%
iShares Russell 2000 Growth ETF
0.03%
詳现を芋る
Virtus LifeSci Biotech Clinical Trials ETF
比率1.24%
Texas Capital Texas Small Cap Equity Index ETF
比率0.24%
ProShares Ultra Nasdaq Biotechnology
比率0.13%
iShares Micro-Cap ETF
比率0.09%
Invesco Nasdaq Biotechnology ETF
比率0.07%
Texas Capital Texas Equity Index ETF
比率0.05%
iShares Biotechnology ETF
比率0.03%
ProShares Hedge Replication ETF
比率0.03%
Invesco RAFI US 1500 Small-Mid ETF
比率0.03%
iShares Russell 2000 Growth ETF
比率0.03%
KeyAI
î™